Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.

J.C. Strefford, L. Kadalayil, J. Forster, M.J. Rose-Zerilli, A. Parker, T.T. Lin, N. Heppel, K. Norris, A. Gardiner, Z. Davies, D. Gonzalez de Castro, M. Else, A.J. Steele, H. Parker, T. Stankovic, C. Pepper, C. Fegan, D. Baird, A. Collins, D. CatovskyD.G. Oscier

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)
Original languageEnglish
Pages (from-to)2411-2414
Number of pages4
Issue number12
Early online date04 Sep 2015
Publication statusPublished - Dec 2015


  • Disease Progression
  • Genes, p53
  • Humans
  • Immunoglobulin Heavy Chains
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Mutation
  • Telomere

Cite this